- Home
- WPM vs HLN Comparison
WPM vs HLN Comparison
Compare WPM & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WPM
- HLN
- Stock Information
- Founded
- WPM 2004
- HLN 2022
- Country
- WPM Canada
- HLN United Kingdom
- Employees
- WPM N/A
- HLN N/A
- Industry
- WPM Precious Metals
- HLN Package Goods/Cosmetics
- Sector
- WPM Basic Materials
- HLN Consumer Discretionary
- Exchange
- WPM Nasdaq
- HLN Nasdaq
- Market Cap
- WPM 40.9B
- HLN 48.2B
- IPO Year
- WPM 2004
- HLN N/A
- Fundamental
- Price
- WPM $92.10
- HLN $9.68
- Analyst Decision
- WPM Strong Buy
- HLN Buy
- Analyst Count
- WPM 8
- HLN 1
- Target Price
- WPM $87.88
- HLN $10.95
- AVG Volume (30 Days)
- WPM 1.7M
- HLN 12.4M
- Earning Date
- WPM 08-07-2025
- HLN 08-12-2025
- Dividend Yield
- WPM 0.69%
- HLN 1.84%
- EPS Growth
- WPM 4.62
- HLN 38.94
- EPS
- WPM 1.36
- HLN 0.23
- Revenue
- WPM $1,458,244,000.00
- HLN $15,096,588,575.00
- Revenue This Year
- WPM $38.25
- HLN $1.93
- Revenue Next Year
- WPM $2.93
- HLN $4.10
- P/E Ratio
- WPM $67.61
- HLN $20.86
- Revenue Growth
- WPM 32.76
- HLN N/A
- 52 Week Low
- WPM $53.05
- HLN $8.86
- 52 Week High
- WPM $96.83
- HLN $11.42
- Technical
- Relative Strength Index (RSI)
- WPM 52.69
- HLN 41.22
- Support Level
- WPM $90.39
- HLN $9.41
- Resistance Level
- WPM $94.23
- HLN $9.85
- Average True Range (ATR)
- WPM 2.43
- HLN 0.13
- MACD
- WPM -0.16
- HLN 0.02
- Stochastic Oscillator
- WPM 46.67
- HLN 47.79
About WPM Wheaton Precious Metals Corp (Canada)
Wheaton Precious Metals Corp is a precious metal streaming company. The company metal streaming company which generates its revenue primarily from the sale of precious metals (gold, silver and palladium) and cobalt. Its reportable segment includes: Gold, Silver, Palladium, Platinum, Cobalt, and Other.
About HLN Haleon plc (Each representing two)
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.